retatrutide study news today Eli Lilly says next-generation weight loss drug clears crucial obesity trial An experimental weight-loss drug from

Self-monitoring during use should note any new lumps, bumps, skin changes, unexplained weight loss, fatigue, or other symptoms that could potentially indicate cancer development

Sulfasalazine microparticles targeting macrophages for the treatment of inflammatory diseases affecting the synovial cavity

Elizabeth Bahar Houshmand , MD , is a double board-certified dermatologist and the founder of Houshmand Dermatology and Wellness in Dallas, Texas

Results In the present study, we conducted RNA-Seq analysis for the fungus Paraphysoderma sedebokerense , which can infect the astaxanthin-producing microalga Haematococcus pluvialis